(Q40231478)
Statements
Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenic trioxide as first-line treatment of acute promyelocytic leukemia: a multicenter randomized controlled trial (English)
Hong-Hu Zhu
De-Pei Wu
Jie Jin
Jian-Yong Li
Jun Ma
Jian-Xiang Wang
Hao Jiang
14 October 2013